chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fatigue/tiredness Narrative: Patient stayed in bed most of the day after vaccination and remained weak and tired for about 4 days after - slept more than usual on these days. 1 week after vaccination still feels fatigue but not napping as much.
Gradual onset of joint pains, especially knees, hips, fingers and wrists. Treated with Aleve and Celebrex. Symptoms continue to worsen.
Lime/citrus taste in mouth between 24 and 42 hours of vaccination; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 16:00(at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder and  lavender and mollusks allergy. The patient previously received Amoxicillin (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN,60mg), ascorbic acid (VITAMIN C,1000mg) levocetirizine dihydrochloride (XYZAL,5mg) all from unknown date for unknown indication. The patient previously took first dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Mar2021 at 12:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 08:00 the patient experienced Lime/citrus taste in mouth between 24 and 42 hours of vaccination. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event Lime/citrus taste in mouth between 24 and 42 hours of vaccination was recovered on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever up to 102.4, tachycardia to 140, fatigue, chills, pain under left axilla, weakness, generalized body aches
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On 23-JUL-2015 the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # K009745, expiry date 17-FEB-2016, dose and dose number were unspecified) orally. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
p/receiving MMR pt fainted; pt was helped up; nurse took pulse, BP pt rested for 1 hr & had orange juice;
Pneumovax Shot was given on Wednesday 11/26/2008 and the next day on Thursday evening 11/27/2008 he began to have a fever and localized swelling and on Friday 11/28/2008 he had 3 hives. The mother administered 3 tablets of Aleve which the Dr told her to do Tylenol for the fever and Allegra plus Benadryl was given for the hives.
chills, Fever (102 degrees), severe body ache, headache, nausea, extreme fatigue, eye sockets ached, drawn No treatment other than stay in bed. Fever broke after 18 hours. Other adverse symptoms lasted 8 days.
Fever 102.5 degrees for almost 3 days, chills, dizziness, nausea, vomiting (could not eat or keep food down for 3 days) Diarrhea for 1 day
Pain in localized area where vaccine was received (left tricep). By next day pain continued in tricep and moved to bicep. Large red, blotchy hives on tricep and bicep - hot to the touch. Chest felt tight, shortness of breath. Low grade fever (100.6). Pain in left side of chest which ran down left arm. Treated at clinic twice, hospitalized. Given prednisone, breathing treatment, Benadryl, pain meds.  9/10/07 Received medical records from 2nd hospital which reveals patient experienced dyspnea, chest pain & hypoxemia.  Admitted from 7/6-7/8/07.  Sent to hospital from current pcp office.  No health problems prior to vax on 6/22 which she received at previous pcp office.  Had redness, swelling & hives on left arm injection site initially then developed pleuritic type chest pain & SOB.  Seen at urgent care center for severe allergic reaction.  Tx w/steroids, antihistamines & neb & released to home. Returned several times to urgent care for same s/s, then to pcp then to outlying ER where she was found to be tachycardic & had DVT of left arm.  Dx from ER: pulmonary embolism & started on heparin.  Consult by cardio & pulmon.  Based on clinical s/s, continued tx for PE w/Coumadin.  D/C to home & new pcp f/u.  No improvement in s/s while home x 4 days & was admitted to this hospital for additional w/u.  On day of admit, was hypoxemic on RA w/O2 sat of 89%.  Pulmo consult obtained.  Placed on heparin drip.  Still felt that clinically had PE w/emboli too small to be detected.  Hypoxia resolved, had mild residual left chest pain.  D/C to home & pulmon f/u. FINAL DX: dyspnea, hypoxia & pleuritic left side chest pain secondary to PE in spite of negative CT angiogram & VQ scan; recent diagnosis of LUE DVT s/p pneumococcal vax. 9/10/07 Received former pcp medical record of 6/22/07 which reveals patient in office for routine annual exam.  Routine vax questioning revealed never to pneumovax.  Exam revealed slight tightness of chest thought to be allergy related.  Diffuse cervical lymphadenopathy anteriorly bilaterally.  9/17/07 Reviewed initial hospital records of 6/27-7/2/2007 admission which reveal patient experienced SOB, left arm swelling & pleuritic chest pain.  Tx w/anticoagulants, nebs, antihistamine & steroids.  Pulm consult obtained.  OB/GYN consulted for heavy menses & birth control.  Cardio consul for tachycardia.  Improved & d/c to home on continuing anticoagulant & antihistamine. FINAL DX: LUE DVT; allergic reaction; possible PE; hx of polycystic ovarian disease; hypoxia, SOB secondary to PE; pleuritic chest pain secondary to PE. 9/28/07 T/C to provider to request vax lot #.  Provided via phone & VAERS database updated w/same.
developed shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (developed shingles) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced HERPES ZOSTER (developed shingles). The patient was treated with ACYCLOVIR [ACICLOVIR] for Shingles, at an unspecified dose and frequency and CALAMINE for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (developed shingles) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Herpes virus test: positive positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No concomitant medications reported.
Days 1-2; Extreme fatigue and chills. Day 3: Felt well.  Starting on Day 4: Extreme Exhaustion, muscle weakness, extreme post-exertional malaise, headache, rash on left cheek, cognitive problems (word-finding difficulty). Symptoms severe for a month, and slow improvement. I'm 2 months out and am at less than 50% of previous activity level. Muscle weakness (especially legs), moderate fatigue, and worsening fatigue after even mild exertion persists. I have had ME/CFS for 25 years, but it was mild/moderate have been at a great functioning level for over 10 years, able to exercise, easily perform ADLS. No problems with muscle weakness, etc.
A week after I received the vaccine i tore my bicep in the same arm helping someone change a tire. All I did was pick up a tire with both hands with a proper base and lifting motion, then i turned the tire about 2 inches to line line up with the lug nuts and I heard a loud velcro tearing noise. It really wasnt alot of weight so Im still confused as to how it happened.
Nausea, disequilibria, diarrhea for about 8 hours.  Return to normal.
A patient potentially received an expired Moderna vaccine past 24 hours in room temperature.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient potentially received an expired Moderna vaccine past 24 hours in room temperature.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient potentially received an expired Moderna vaccine past 24 hours in room temperature.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A patient potentially received an expired Moderna vaccine past 24 hours in room temperature.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.  A vial was potentially left in room temperature for more than 24 hours.
pt recvd vax; T 102-105; no oth sxs, CBC(WBC 8,000);
0930 itching all over, swelling of face and eyelids. Small pruritic erythema blanching papules diffusely, no SOB, alert. 1009 Orapred 15/5 tsp po given, Benadryl 1/2 tsp po given, and Epinephrine 1:1000 0.2ml SQ given. 1030 rash subsided and swelling to face decreased.
WBC count spiked to 14,000-23,000; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of WHITE BLOOD CELL COUNT INCREASED (WBC count spiked to 14,000-23,000) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic lymphocytic leukemia. Concomitant products included IBRUTINIB (IMBRUVICA) and VENETOCLAX (VENCLEXTA) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced WHITE BLOOD CELL COUNT INCREASED (WBC count spiked to 14,000-23,000). At the time of the report, WHITE BLOOD CELL COUNT INCREASED (WBC count spiked to 14,000-23,000) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, White blood cell count: 14,000-23,000 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Since 2017, patient was taking Imbruzica 420mg 1/day. It's worked well. His new medicine is Venclexta 200mg at 8p tonight. It's being titrated up to a 400mg daily dose. he will receive IV treatment of Retuxin on his next appointment. he gets that every 28 days,its a 6 dose treatment.    treatment medication information was not provided.
Family member came  in to clinic with child at 1:13 pm stated Lt arm red, and swollen, notice Lt arm with swelling and redness present in SQ area where Varicella had been administered, ask family member about application of cool compress, stated, no.
Information has been received from a medical assistant concerning a female physician who on 05/30/2002, while administering a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella vaccine live (second generation) was "inadvertently splashed in her eye". It was reported that the physician "got a small quantity (several drops in her eye)." The physician reported that her eye "feels funny but is not read or inflamed". The physician sought medical attention. Additional info has been requested.
Breakthrough case admission after 2 vaccines Moderna 4/5/21 lot# 031B21A;  Moderna 5/3/21 Lot# 004C21A
Redness, swelling and pain. Treated with benadryl and ice. Symptoms resolved in 72 hours.
report of pt who exp temporal arteritis p/1st dose of Engerix-B; treatment unk;
This spontaneous report was received from a physician via company representative and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 01-FEB-2016, the patient was vaccinated with an improperly stored PEDVAXHIB Single Dose Vaccine, 10-pack, lot number K004541, expiration date 04-DEC-2016, (dose, route  and anatomical location were not reported). The improperly stored PEDVAXHIB was in a Refrigerator, and the highest temperature of excursion was 47 Fahrenheit degrees (8.33 Celsius degrees) with a sum of 24 hours of excursion. No adverse effects were reported and no product quality complain was involved. This is one of several reports from the same reporter. Additional information has been requested.
Metal taste in mouth during 15 minute after shot, 35 minutes later tingling on mouth area and then tingling and shooting pain on entire face area.  Went back to clinic and they gave me 2 Benadryl 50 mg and monitored my blood pressure.  Was high when I got in and after Benadryl dropped significantly.  I was told to take 2 Benadryl at 6pm which I did.  Tingling stopped with Benadryl.  Not feeling right for next 5 days with shortness of breath, chest pains and blood pressure fluctations from high to low. Went back on 1/28/2021  PA did EKG and suggested that I see my cardiologist.  On evening of 1/29/2021 I experienced heart racing, chest pain, shortness of breath, cough and then extreme throat pain. Took 1 benadry
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX, 1 DF for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to ZOSTAVAX. Additional information has been requested.
Fever of 102+ degrees. Body aches. Nausea/vomiting. Fatigue. Hot flashes. Pain at injection site. Treated with rest, fluids, acetaminophen for fever/body aches.
This spontaneous report was received from a pharmacist via a company representative on 07OCT2015 which refers to an unspecified patient (unknown age and gender) who received a dose of ZOSTAVAX intramuscularly (site of injection was not specified) on an unspecified date. The pharmacist reported that the patient experienced a wheal, for an unspecified period of time, at the injection site of ZOSTAVAX. No additional information was provided about this patient. The outcome of the events was unknown. Additional information has been requested. This is one of several reports from the same source.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received SHINGRIX (batch number TP5E5, expiry date 15th November 2020) for prophylaxis. On 19th June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the dose was an unknown dose. On 19th June 2018, immediately after receiving SHINGRIX, the patient experienced injection site pain, injection site bruising, injection site erythema and injection site lump. On an unknown date, the outcome of the injection site pain, injection site bruising, injection site erythema and injection site lump were recovered/resolved. It was unknown if the reporter considered the injection site pain, injection site bruising, injection site erythema and injection site lump to be related to SHINGRIX. Additional details reported as follows: The patient immediately experienced pain, soreness, bruising, and a big red knot at the injection site after receiving SHINRIX. It resolved within 2 weeks. No additional information provided.
Left sore arm; Fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Left sore arm), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high since 12-Dec-2012. Concomitant products included LOSARTAN and HYDROCHLOROTHIAZIDE for Hypertension.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Left sore arm), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, MYALGIA (Left sore arm), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications include blood pressure medications.   This case was linked to MOD-2021-325355 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received and medical history updated, concomitant medication updated.
pt recv vax 18APR96 & devel an inj site rxn, characterized by redness, warmth & swelling;no further details were known as of the date of this report;this is 1 of 2 patients from this site & lot# to report adverse rxn;
Initial medication error report received on 09 October 2013 from a Nurse. A patient's whose gender, age, medical history and concomitant medications were not reported, received a dose of FLUZONE (route, lot number and site of vaccination was not reported) on an unspecified date.  Nurse inadvertently administered 0.25 ml to adult patient instead of 0.5 ml dose. List of documents held by sender: none.
A nurse reported that a 48-year old female received an injection of Flu Shield (2001-2002 formula) on 08-Nov-2001 and the next day, experienced tenderness at her left neck base, left chest wall and laterally into her left breast. The patient was diagnosed with myositis and prescibed propoxyphene napsylate. She felt better the next day. The reporter spoke with the patient on 13-NOV-2001 and she was much better. This is 1 of 2 patients from this facility who experienced an adverse event following receipt of flu shield (2001-2002 Formula). See MSN HQ895892NOV2001. Additional information received 20-Dec-2001 indicated that the patient recovered.
mild headache; felt lethargic; tired; felt sore at the injection site; body aches; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (mild headache), LETHARGY (felt lethargic), FATIGUE (tired), INJECTION SITE PAIN (felt sore at the injection site) and MYALGIA (body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced HEADACHE (mild headache), LETHARGY (felt lethargic), FATIGUE (tired), INJECTION SITE PAIN (felt sore at the injection site) and MYALGIA (body aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 17-Jan-2021, HEADACHE (mild headache), LETHARGY (felt lethargic), FATIGUE (tired), INJECTION SITE PAIN (felt sore at the injection site) and MYALGIA (body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-022368 (Patient Link).
No actual adverse events noted; however, upon billing the vaccine on 5/10/2021, the claim would not pay. This person already received their second dose. Per audit, the patient received doses on 12/22/2020, 4/15/2021 and 5/6/2021.
72 hours after vaccine (Saturday) she started having diarrhea that lasted 72 hours, at which point the diarrhea stopped and fever began (Monday night) and has continued through today (Tuesday). She has been unusually irritable since Sunday evening which has also carried through and continues today.
Abdominal pain that comes and goes; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: FW0182 and expiration date was not reported), via an unspecified route of administration in left arm, on 17May2021 at 11:30 (at the age of 34 year old) as 2nd dose, single for COVID-19 immunization in a Pharmacy or Drug Store. Medical history included penicillin allergy. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: unknown and expiration date was not reported), via an unspecified route of administration in right arm, on 20Apr2021 at 11:30 (at the age of 34 year old) as 1st dose, single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The patient experienced abdominal pain that comes and goes on 18May2021 at 12:00. The event was considered non-serious. No treatment was received for this event. The outcome of the event was not recovered at the time of report.
PROQUAD stored at -5°C for 20 hours was administered to the patient; This spontaneous report was received from a register nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, drug reactions or allergies, pertinent medical history and concomitant therapies were not reported.      On 04-DEC-2020, the patient was vaccinated with an incorrect storage dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # T021302 (also reported as T0l 1302 which is non-valid for measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) is valid for sitagliptin phosphate (XELEVIA)) , expiration date 19-DEC-2021, 0.5 milliliter for prophylaxis (route not reported). The temperature excursion occurred on 2 separate dates at -5 Celsius degrees (°C) for 20 hours. There was no previous temperature excursion. The call was made due to "data logger".  The register nurse also reported that varicella virus vaccine live (manufacturer unknown) had temperature excursion (temperature and time were not reported). It was unknown if this vaccine was administered.        This is one of two reports from the same reporter.; Sender's Comments:  US-009507513-2101USA003511:
The day of vaccination had general soreness.  Over a week later the soreness spread to my shoulders, side, and neck.  It got worse to the point to where I could not sleep through the night, and the pain is continuous.